MOLN CIK: 1745114

Molecular Partners AG ADR

  • Switzerland
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions CHF
FY21:
164
FY22:
255
FY23:
192
FY24:
154
FY25:
96.9
(positive)
Change from FY21 to FY25
millions CHF
FY21:
8.48
FY22:
7.51
FY23:
5.89
FY24:
4.25
FY25:
5.23
Total assets
Change from FY21 to FY25
millions CHF
FY21:
173
FY22:
262
FY23:
198
FY24:
159
FY25:
102

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions CHF
FY21:
46.9
FY22:
17.3
FY23:
14.4
FY24:
10.8
FY25:
11.0
(negative)
Change from FY21 to FY25
millions CHF
FY21:
18.5
FY22:
9.84
FY23:
7.51
FY24:
6.11
FY25:
10.7
(positive)
Change from FY21 to FY25
millions CHF
FY21:
107
FY22:
235
FY23:
176
FY24:
142
FY25:
80.3
Total liabilities & equity
Change from FY21 to FY25
millions CHF
FY21:
173
FY22:
262
FY23:
198
FY24:
159
FY25:
102

All amounts in millions CHF Data source:SEC EDGAR